{"id":142884,"date":"2025-01-17T12:43:02","date_gmt":"2025-01-17T07:13:02","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=142884"},"modified":"2025-01-17T12:43:06","modified_gmt":"2025-01-17T07:13:06","slug":"pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/","title":{"rendered":"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1683939510\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India.<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-705611344\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of Rs. 1,774.66 crores on Friday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/BAJAJHCARE\" target=\"_blank\" rel=\"noreferrer noopener\">Bajaj Healthcare Limited<\/a><\/strong> is trading at Rs. 643.20 up by 16.4 percent making a high of Rs. 654 per share compared to its previous closing price of Rs. 561.55\u00a0 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p>Bajaj Healthcare Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals. The company has secured exclusive rights from Threotech LLC for the manufacturing, distribution, and sale of the finished formulation of Magnesium L Threonate (Magtein\u00ae) in India.<\/p><p>Along with it,&nbsp; the company will have the opportunity to enter into marketing collaborations with leading pharmaceutical firms in India. Bajaj Healthcare, which is already supplying the API for Magtein\u00ae in the U.S., where the brand has a sales value of approximately USD 438 million, will now strengthen its presence in the Indian market.<\/p><div class=\"trade-content_5\" id=\"trade-806468984\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>This new development further strengthens Bajaj Healthcare\u2019s position as a trusted partner in the pharmaceutical industry, leveraging its strong domestic presence and manufacturing expertise to tap into the growing market potential for Magnesium L Threonate in India.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Business segment&nbsp;<\/strong><\/h2><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Segment I: Active Pharmaceutical Ingredients (APIs)<\/strong><\/h3><p>Bajaj Healthcare is a major API manufacturer in India, exporting to over 50 countries. API manufacturing contributes over 90 percent of its revenue, with a capacity of 730 MT per month. The company focuses on R&amp;D to support continuous growth.<\/p><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Segment II: Finished Dosage Formulations (FDFs)<\/strong><\/h3><p>Bajaj Healthcare\u2019s manufacturing facility is compliant with USFDA, TGA (Australia), and MHRA (UK) standards. The company offers tablets, capsules, and oral powders, all available in bulk quantities, contributing 10 percent to total revenue. Its automated processes ensure high-quality production.<\/p><h3 class=\"wp-block-heading has-medium-font-size\"><strong>Segment III: Intermediates<\/strong><\/h3><p>Bajaj Healthcare manufactures intermediates such as CPCC and Chlorhexidine, with an annual capacity of 94 MT. These intermediates support API and FDF production, enhancing cost-effectiveness and economies of scale.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials&nbsp;<\/strong><\/h2><p>The company&#8217;s revenue rose by 32.4 percent from Rs&nbsp; 102.43 crore to Rs 135.7 crore in Q2FY24-25. Meanwhile, Net profit rose from&nbsp; a loss of Rs&nbsp; 3.46 crores to a profit of&nbsp; Rs 9.46 crore during the same period.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar J<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-791823627\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-4182657451\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India. Price action With a market capitalization of Rs. 1,774.66 crores on Friday, the shares of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25548,16926,16925,6616,948,936,3157],"class_list":["post-142884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-bajaj-healthcare","tag-bajaj-healthcare-latest-news","tag-bajaj-healthcare-share-price","tag-pharma-stock","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India\" \/>\n<meta property=\"og:description\" content=\"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-17T07:13:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-17T07:13:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/\",\"name\":\"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2025-01-17T07:13:02+00:00\",\"dateModified\":\"2025-01-17T07:13:06+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India - Trade Brains Features","description":"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India","og_description":"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-01-17T07:13:02+00:00","article_modified_time":"2025-01-17T07:13:06+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/","name":"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2025-01-17T07:13:02+00:00","dateModified":"2025-01-17T07:13:06+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of one of the leading Pharmaceuticals stocks, specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals, jumped up to 16 percent upon securing exclusive licensing rights for sale of Magnesium L Threonate in India","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-16-after-receiving-rights-to-manufacture-and-sell-magtein-in-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 16% after receiving rights to manufacture and sell Magtein in India"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=142884"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142884\/revisions"}],"predecessor-version":[{"id":142889,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/142884\/revisions\/142889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=142884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=142884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=142884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}